2022
DOI: 10.1007/164_2022_611
|View full text |Cite
|
Sign up to set email alerts
|

Natural Products Drug Discovery: On Silica or In-Silico?

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2023
2023

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 63 publications
0
1
0
Order By: Relevance
“…Hyphenated HPTLC and metabolomics are both excellent tools for simultaneous non-target bioprofiling of samples, whereby the investigation of the bioactivity is performed on-surface via HPTLC (Schreiner & Morlock, 2021 ; Schreiner et al, 2021 ) versus usually in silico via metabolomics. Both overcome laborious steps of bioactivity-guided fractionation of crude plant extracts (Kim et al, 2023 ).…”
Section: Introductionmentioning
confidence: 99%
“…Hyphenated HPTLC and metabolomics are both excellent tools for simultaneous non-target bioprofiling of samples, whereby the investigation of the bioactivity is performed on-surface via HPTLC (Schreiner & Morlock, 2021 ; Schreiner et al, 2021 ) versus usually in silico via metabolomics. Both overcome laborious steps of bioactivity-guided fractionation of crude plant extracts (Kim et al, 2023 ).…”
Section: Introductionmentioning
confidence: 99%